Artidis Company
ARTIDISTM is our nanomechanical sensor that captures the physical properties of tissue enabling the clinician to differentiate between benign and malignant tissue in under three hours.
Estimated Revenue:
$1M to $10M
Industry:
BioTech
Technology:
Nanotechnology
Founded Date:
2017
Headquarters:
Basel
Total Funding:
CHF8.8M
Employee Number:
11-50